Bessemer Group
ARLZ

Bessemer Group’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Bessemer Group’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-68
Closed – – 1930
2019
Q1 		$0 Buy
+68
New – ﹤0.01% 2120

Bessemer Group's ARLZ Position: Q2 2019 in Review

Bessemer Group sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q2 2019, closing a stake of 68 shares.

Bessemer Group first reported a position in ARLZ in Q1 2019 and held it in 1 quarter. The position peaked at $0 in Q1 2019. 1 fund tracked by Wall St. Rank holds ARLZ as of Q2 2019.

  • Bessemer Group reported no remaining Aralez Pharmaceuticals Inc. position as of Q2 2019 after selling out during the quarter.
  • Bessemer Group sold 68 Aralez Pharmaceuticals Inc. shares in Q2 2019.
  • Bessemer Group first reported a position in Aralez Pharmaceuticals Inc. in Q1 2019 and held it in 1 quarter.
  • Bessemer Group's Aralez Pharmaceuticals Inc. position peaked at $0 in Q1 2019.
  • 1 fund tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q2 2019.

Based on Bessemer Group's 13F filing for Q2 2019, filed 19 Jul 2019.